New class of iron-targeting compounds found to hamper proliferation of cancer cells

Researchers at the University of Arizona Cancer Center discovered a new class of iron-targeting compounds that hamper the proliferation of cultured malignant cells in a laboratory setting.

Signal: LimmaTech raises $37m for antimicrobial resistance research – Pharmaceutical Technology

Franz-Werner Haas, LimmaTech CEO. Photo: Thomas Kienzle/AFP via Getty Images. Limmatech, the GSK spinout focusing on antimicrobial resistance, announced on Monday (9 October) that it

October 9, 2023

Gene therapy to prevent stillbirth and premature delivery developed

Researchers investigate the effectiveness of placental nano-based insulin-like 1 growth factor gene therapy to correct fetal growth restriction.

December 12, 2024

FDA gives accelerated approval to Day One’s targeted treatment for most common brain tumor in kids

The FDA granted accelerated approval to Day One Biopharmaceuticals’ pediatric brain tumor treatment. The regulator on Tuesday approved tovorafenib, taking place more than five years

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.